Almirall Prodesfarma S.A., J&J sales and marketing update

JNJ's Ortho-McNeil Pharmaceutical Inc. and Janssen-Ortho Inc. units received U.S. and Canadian marketing rights to Almirall's Axert almotriptan to treat migraine. The compound previously was license...